TrademarkDir
TRICIDE-NEO
DEAD

Serial Number

78264415

Owner

Molecular Therapeutics

Filing Date

Jun 19, 2003

Add to watchlist:

No watchlists yet
+ Create New Watchlist
View on USPTO

TRICIDE-NEO Trademark

Serial Number: 78264415 • Registration: 2897249

TRICIDE-NEO is a trademark filed by Molecular Therapeutics on June 19, 2003. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently no longer active.

Owner Contact Info

Molecular Therapeutics (9 trademarks)

425 River Rd, Suite 422
Athens, GA 30602

Entity Type: 13

Trademark Details

Filing Date

June 19, 2003

Registration Date

October 26, 2004

Published for Opposition

August 3, 2004

Cancellation Date

May 9, 2025

Goods & Services

Chemical potentiate of antibiotics to facilitate treatment and prevention of microbial colonization of epithelial and mucosal surfaces for medical use and antibiotics to facilitate treatment and prevention of microbial colonization of epithelial and mucosal surfaces for medical use

Filing History

CANCELLED SEC. 8 (10-YR)/EXPIRED SECTION 9
May 9, 2025 CAEX
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Oct 26, 2023 REM2
NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
Oct 23, 2014 NA89
REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
Oct 22, 2014 RNL1
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
Oct 22, 2014 89AG
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Oct 21, 2014 APRE
TEAS SECTION 8 & 9 RECEIVED
Oct 8, 2014 E89R
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Oct 8, 2014 TCCA
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Oct 22, 2010 C15A
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Oct 22, 2010 APRE
TEAS SECTION 8 & 15 RECEIVED
Oct 15, 2010 E815
REGISTERED-PRINCIPAL REGISTER
Oct 26, 2004 R.PR
PUBLISHED FOR OPPOSITION
Aug 3, 2004 PUBO
NOTICE OF PUBLICATION
Jul 14, 2004 NPUB
APPROVED FOR PUB - PRINCIPAL REGISTER
May 21, 2004 CNSA
EXAMINERS AMENDMENT E-MAILED
May 18, 2004 GNEA
NON-FINAL ACTION E-MAILED
Nov 20, 2003 GNRT
ASSIGNED TO EXAMINER
Nov 11, 2003 DOCK

Related Trademarks

More from this Owner

SILVAKLENZ

SILVAKLENZ

SILVAKLENZ

SILVAKLENZ

MOLECULAR THERAPEUTICS

MOLECULAR THERAPEUTICS

MOLECULAR THERAPEUTICS

MOLECULAR THERAPEUTICS

MOLECULAR THERAPEUTICS

MOLECULAR THERAPEUTICS

SILVAKLENZ

SILVAKLENZ